{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T03:03:19Z","timestamp":1775098999530,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T00:00:00Z","timestamp":1591142400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T00:00:00Z","timestamp":1591142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>To examine, if a shift in indications for radiotherapy is to be expected in the context of the COVID-19 pandemic, the database Pubmed was searched for multidisciplinary or surgical expert recommendations on the role of radiotherapy in modified treatment concepts. Increased use of radiotherapy or chemoradiation instead of surgical treatment was recommended for defined patient groups with head-and-neck cancer, lung cancer, cervix cancer, esophageal cancer and prostate cancer. Omission of radiotherapy was considered in elderly patients with low-risk breast cancer and in early-stage Hodgkin\u2019s lymphoma. Only adjustments to the timing of radiotherapy were discussed for sarcoma and rectal cancer. Emerging recommendations on multidisciplinary cancer treatment concepts during the COVID-19 pandemic indicate a shift in radiotherapy indications and a potentially increased demand for radiotherapy.<\/jats:p>","DOI":"10.1186\/s13014-020-01579-3","type":"journal-article","created":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T14:47:12Z","timestamp":1591195632000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Shift in indications for radiotherapy during the COVID-19 pandemic? A review of organ-specific cancer management recommendations from multidisciplinary and surgical expert groups"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8816-0508","authenticated-orcid":false,"given":"Dirk","family":"Vordermark","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,3]]},"reference":[{"issue":"1","key":"1579_CR1","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13014-020-01527-1","volume":"15","author":"SE Combs","year":"2020","unstructured":"Combs SE, et al. First statement on preparation for the COVID-19 pandemic in large German speaking university-based radiation oncology departments. Radiat Oncol. 2020;15(1):74.","journal-title":"Radiat Oncol"},{"issue":"5","key":"1579_CR2","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.clon.2020.03.006","volume":"32","author":"CE Coles","year":"2020","unstructured":"Coles CE, et al. International guidelines on radiation therapy for breast cancer during the COVID-19 pandemic. Clin Oncol (R Coll Radiol). 2020;32(5):279\u201381.","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"1579_CR3","doi-asserted-by":"crossref","unstructured":"Braunstein LZ, et al. Breast radiotherapy under COVID-19 pandemic resource constraints -- approaches to defer or shorten treatment from a Comprehensive Cancer Center in the United States. Adv Radiat Oncol. 2020;(Epub).","DOI":"10.1016\/j.adro.2020.03.013"},{"issue":"20","key":"1579_CR4","first-page":"31034","volume":"S0360\u20133016","author":"DJ Thomson","year":"2020","unstructured":"Thomson DJ, et al. Practice recommendations for risk-adapted head and neck cancer radiotherapy during the COVID-19 pandemic: An ASTRO-ESTRO consensus statement. Int J Radiat Oncol Biol Phys. 2020;S0360\u20133016(20):31034\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1579_CR5","unstructured":"Zaorsky NG, et al. Prostate cancer radiotherapy recommendations in response to COVID-19. Adv Radiat Oncol. 2020;(Epub)."},{"issue":"20","key":"1579_CR6","first-page":"30182","volume":"S0167\u20138140","author":"M Guckenberger","year":"2020","unstructured":"Guckenberger M, et al. Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement. Radiother Oncol. 2020;S0167\u20138140(20):30182\u20131.","journal-title":"Radiother Oncol"},{"issue":"20","key":"1579_CR7","first-page":"30930","volume":"S0360\u20133016","author":"AR Filippi","year":"2020","unstructured":"Filippi AR, et al. Letter from Italy: First practical indications for radiation therapy departments during COVID-19 outbreak. Int J Radiat Oncol Biol Phys. 2020;S0360\u20133016(20):30930\u20135.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1579_CR8","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.radonc.2020.03.016","volume":"147","author":"W Wei","year":"2020","unstructured":"Wei W, et al. How should we implement radiotherapy for cancer patients in China during the endemic period of COVID-19? Radiother Oncol. 2020;147:100\u20132.","journal-title":"Radiother Oncol"},{"key":"1579_CR9","unstructured":"COVID-19 rapid guideline: delivery of radiotherapy. NICE guideline [NG162] Published date: 28 March 2020 (https:\/\/www.nice.org.uk\/guidance\/ng162;accessed May 15 2020)."},{"key":"1579_CR10","doi-asserted-by":"publisher","first-page":"104684","DOI":"10.1016\/j.oraloncology.2020.104684","volume":"105","author":"AT Day","year":"2020","unstructured":"Day AT, et al. Head and neck oncology during the COVID-19 pandemic: reconsidering traditional treatment paradigms in light of new surgical and other multilevel risks. Oral Oncol. 2020;105:104684.","journal-title":"Oral Oncol"},{"issue":"20","key":"1579_CR11","first-page":"30070","volume":"S1878\u20137886","author":"JJ Tuech","year":"2020","unstructured":"Tuech JJ, et al. Strategy for the practice of digestive and oncological surgery during the Covid-19 epidemic. J Visc Surg. 2020;S1878\u20137886(20):30070\u20139.","journal-title":"J Visc Surg"},{"issue":"20","key":"1579_CR12","first-page":"30157","volume":"S0936\u20136555","author":"CM Jones","year":"2020","unstructured":"Jones CM, et al. Considerations for the treatment of oesophageal cancer with radiotherapy during the COVID-19 pandemic. Clin Oncol (R Coll Radiol). 2020;S0936\u20136555(20):30157\u20136.","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"1579_CR13","doi-asserted-by":"publisher","first-page":"101729","DOI":"10.1016\/j.jogoh.2020.101729","volume":"1","author":"C Akladios","year":"2020","unstructured":"Akladios C, et al. Recommendations for the surgical management of gynecological cancers during the COVID-19 pandemic - FRANCOGYN group for the CNGOF. J Gynecol Obstet Hum Reprod. 2020;1:101729.","journal-title":"J Gynecol Obstet Hum Reprod"},{"issue":"20","key":"1579_CR14","first-page":"36413","volume":"S0923\u20137534","author":"N Penel","year":"2020","unstructured":"Penel N, et al. French Sarcoma Group proposals for management of sarcoma patients during the COVID-19 outbreak. Ann Oncol. 2020;S0923\u20137534(20):36413\u20139.","journal-title":"Ann Oncol"},{"issue":"20","key":"1579_CR15","first-page":"30291","volume":"S1556\u20130864","author":"S Cafarotti","year":"2020","unstructured":"Cafarotti S, Patella M. Lung cancer surgical management during the outbreak of coronavirus disease 2019. J Thorac Oncol. 2020;S1556\u20130864(20):30291\u20134.","journal-title":"J Thorac Oncol"},{"issue":"20","key":"1579_CR16","first-page":"30229","volume":"S0302\u20132838","author":"R Campi","year":"2020","unstructured":"Campi R, et al. Assessing the burden of nondeferrable major uro-oncologic surgery to guide prioritisation strategies during the COVID-19 pandemic: insights from three Italian high-volume referral centres. Eur Urol. 2020;S0302\u20132838(20):30229\u20133.","journal-title":"Eur Urol"},{"key":"1579_CR17","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.breast.2020.04.006","volume":"52","author":"G Curigliano","year":"2020","unstructured":"Curigliano G, et al. Recommendations for triage, prioritization and treatment of breast cancer patients during the COVID-19 pandemic. Breast. 2020;52:8\u201316.","journal-title":"Breast"},{"key":"1579_CR18","doi-asserted-by":"crossref","unstructured":"Mohile NA, et al. Urgent considerations for the neuro-oncologic treatment of patients with gliomas during the COVID-19 pandemic. Neuro-Oncology. 2020:noaa090.","DOI":"10.1093\/neuonc\/noaa090"},{"key":"1579_CR19","doi-asserted-by":"crossref","unstructured":"Perini GF, et al. How to manage lymphoid malignancies during novel 2019 coronavirus (CoVid-19) outbreak: a Brazilian task force recommendation. Hematol Transfus Cell Ther. 2020;(Epub).","DOI":"10.1016\/j.htct.2020.04.002"},{"key":"1579_CR20","doi-asserted-by":"crossref","unstructured":"Nagar H, Formenti SC. Cancer and COVID-19 - potentially deleterious effects of delaying radiotherapy. Nat Rev Clin Oncol. 2020;27.","DOI":"10.1038\/s41571-020-0375-1"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-020-01579-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-020-01579-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-020-01579-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T02:06:15Z","timestamp":1622685975000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-020-01579-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,3]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1579"],"URL":"https:\/\/doi.org\/10.1186\/s13014-020-01579-3","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,3]]},"assertion":[{"value":"28 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval was not required for this review article.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The final manuscript has been approved by the sole author.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The author declares there are no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"140"}}